Sentences with phrase «radiation therapy patients»

Guinan, a bone marrow transplant specialist, began by asking her radiation therapy patients to provide her with fingernail and toenail clippings.

Not exact matches

For instance, most common adult solid tumors that are not cured by surgical removal are resistant to chemotherapy or radiation control, yet drug therapy is frequently offered as a «possibly effective» treatment because both patient and physician want to believe it so.

Stomatorrhagia (bleeding in the mouth) is commonly seen in patients undergoing chemotherapy and / or radiation therapy.

There was also no change based on whether patients had undergone hormone therapy, a common treatment for prostate cancer which lowers the male hormone and can be combined with daily radiation.

Currently, most breast cancer patients are treated not only with surgery, but also radiation, hormone therapy or chemotherapy.

Unlike conventional chemotherapies and radiation that indiscriminately eradicate fast - growing tissues and ravage people's bodies with side effects, new therapies specifically target tumors using tailored cells from individual patients.

The Moores Cancer Center's Molecular Tumor Board brought together medical, surgical and radiation therapy oncologists, biostatisticians, radiologists, pathologists, clinical geneticists, basic and translational science researchers, and bioinformatics and pathway analysis specialists to discuss the intricacies of tumor genetics and tailor a personalized treatment plan for patients with advanced cancer or who have exhausted standard therapies.

Urbanic said the overall findings of the study suggest that there are some patients with recurrent lung cancers who can be treated with another definitive course of radiation therapy and still have a chance at a cure.

Despite complications sometimes more severe than with standard radiation therapy — and costs that are much higher for taxpayers, patients and insurers — proton beam therapy is heavily marketed for treatment of prostate cancer.

Inside the University of Pennsylvania's Roberts Proton Therapy Center, radiation oncologists sit in front of colorful, detailed images of patients» bodies, clicking mice and tapping keyboards.

This study analyzed preserved tumor samples from 43 prostate cancer patients who later received radiation therapy after rising PSA levels were detected following a radical prostatectomy.

A new study has identified a group of molecules in prostate - cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels indicate their cancer has recurred after surgical removal of the prostate.

«Cervical cancer patients are currently treated as a uniform group based on chemotherapy and radiation regimens that help the largest percentage of people; however, one third of these patients are not helped by standard therapies,» Banister said.

In particular, the study suggests that two miRNAs — miR - 4516 and miR - 601 — in tumor cells along with Gleason score and lymph node status may help identify patients who might experience rising PSA after they've been treated with radiation therapy.

«These findings are important because it is currently hard to distinguish early which patients will benefit from radiation therapy following radical prostatectomy and which will receive no benefit,» says Bell.

«There's this commonly held belief that the longer you delay radiation therapy, the more opportunity a patient has for recovery from prostatectomy, and therefore the better long - term function in terms of urinary and bowel function — the longer you delay it, the better they'll function,» he said.

But up to 30 to 40 percent of these patients experience rising PSA levels after surgery, and these patients are often treated using radiation therapy.

Led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in tumor cells might predict patients» response to radiation therapy.

Researchers compared two common postsurgical therapies for metastatic brain tumors and found that stereotactic radiosurgery can provide better outcomes for patients compared to whole - brain radiation.

«The use of advanced technologies may allow radiation therapy to be delivered in larger doses per treatment safely and potentially translate into an overall survival difference in NSCLC patient populations while improving patient quality of life through an acceleration of treatment courses,» said Dr. Iyengar.

Treatments include surgery to remove the prostate, radiation therapy and active surveillance during which patients are continuously monitored.

The Chinese trial will enrol patients who have metastatic non-small cell lung cancer and for whom chemotherapy, radiation therapy and other treatments have failed.

«Extremely hypofractionated radiation therapy shows promising toxicity results for intermediate risk prostate cancer patients.»

Early in the 20th century, radiation therapy was also an emerging cancer treatment, and the nation's preeminent cancer pathologist, James Ewing, staunchly favored treating patients with this promising new method.

Stamets furnished capsules of freeze - dried fungus for a seven - year, NIH - funded study by Bastyr University and the University of Minnesota to determine whether turkey tail mushrooms could help breast cancer patients whose immune systems had been compromised by radiation therapy.

Lead investigator, Evan Matros, MD, FACS, explained that today plastic surgeons are more willing to perform reconstructive procedures in these patient groups — which include women age 65 and older or those who have had radiation therapy — than they were 15 years ago, and that patients themselves are more accepting of these reconstruction procedures.

Nearly half of all cancer patients receive radiation therapy to curb the growth of malignant cells.

Three patient samples were positive for ALK — these patients with peritoneal mesothelioma were women with no history of asbestos or radiation therapy exposure.

This study used the National Cancer Data Base to analyze 9,817 patients and found that patients treated at higher - volume facilities were more likely to have shorter radiation therapy duration than those at lower volume facilities.

Of the 751 patients, 520 (69.2 %) received chemotherapy and radiation therapy and 231 (30.8 %) received only radiation therapy.

In our trial, however, the addition of radiation therapy directed at each of the cancerous areas greatly improved how patients responded to subsequent rounds of chemotherapy,» said Puneeth Iyengar, MD, PhD, lead author of the study and an assistant professor of radiation oncology at the University of Texas Southwestern Medical Center in Dallas.

Knowing that this mutation may render radiation ineffective, patients could be spared that therapy.

The study was a randomized phase II trial testing whether the addition of local treatment, in the form of consolidative radiation therapy, to the standard treatment of systemic therapy improved progression - free survival for patients with limited metastatic NSCLC.

Patients with uveal melanoma receive surgery to remove the tumor — and in some advanced cases, the entire eye — as well as radiation therapy or chemotherapy.

«There is a significant possibility that local therapy, such as consolidative radiation, may become an important part of the management of limited metastatic NSCLC patients, but this validation must take place in randomized phase III studies.

Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial reported today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Thirty - one lesions were treated with radiation in the 14 patients that received local therapy.

None of the recurrences among the latter patients were in areas treated directly with radiation therapy.

The other 200 patients were randomised to dose - escalated external beam radiation therapy (DE-EBRT) and received an additional 32 Gy of external beam radiation to achieve a total prostate dose of 78 Gy.

Trial # 1: A phase I / II trial of HCQ in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

Hormone therapies are used to treat prostate cancer patients whose disease either isn't responding to radiation or surgery or has already spread beyond the prostate gland.

The analysis compared patient consultation rates with cancer specialists as well as treatment with surgery, chemotherapy and radiation therapy for white and black patients.

Such a molecule might also be able to ameliorate the side effects of chemotherapy or radiation therapy of cancer patients.

Two patients that had previously not responded to available standard treatments, including surgery, external radiation, hormonal and chemotherapy, have received 225Actinium - PSMA - 617 as experimental therapy.

Twenty - two patients with elevated prostate - specific antigen and biopsy - proven prostate carcinoma who underwent MRI of the prostate at 1.5 T with endorectal coil were divided into two groups: those who were treated with androgen deprivation, radiation therapy, or both, and a Gleason - matched control group who had not received such therapy.

Preliminary results of a study of patients with prostate cancer show that MR tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation therapy, according to a team of researchers at Brigham and Women's Hospital and Massachusetts General Hospital in Boston.

Since whole - brain radiation is associated with significant cognitive effects and the use of additional radiation therapy for progression is common in this population, the Yale researchers suspect that patients with the ALK mutation would benefit from radiation focused on individual metastases.

Regardless of disease stage, patients who received surgery lived an average of 57 months, compared to less than 12 months for patients who received only non-surgical treatment (such as chemotherapy or radiation therapy), and 1.4 months for patients who received no treatment at all.

The study showed that patients who held their breath during radiation therapy had only a 1.4 percent rate of ischemic heart disease after 8 years of follow up and an estimated rate of 3.6 percent after 10 years.

About 80 percent of patients receiving high - dose, short - course therapies had good cosmetic results, similar to longer - course treatments with smaller radiation doses.